Abstract:Abstract Neonatal lupus erythematosus (LE) is an uncommon clinical condition caused by the transfer of anti-Ro/SSA or anti-La/SSB transplacentally from the mother to the fetus (Costa Cascais F, Fraga S, Sousa S, Pinto M. Neonatal lupus: a clinical challenge. BMJ Case Rep 2021; 14: e246590). The incidence of neonatal LE is about 1 in 20 000 live births, with female neonates twice as likely to be affected compared than male (Sukumaran S, Singh D. Cutaneous neonatal lupus erythematosus: a case report. Cureus 2022; 14: e22279). We report a case of neonatal LE in a 3-month-old male infant who presented with multiple annular erythematous lesions on his scalp and feet. A 3-month-old baby was referred by the general practitioner after multiple annular erythematous lesions were noted on his scalp and feet. He was delivered at term via a spontaneous vertex vaginal birth. The APGAR (appearance, pulse, grimace, activity and respiration) score was 9 at 1 min and 10 at 5 min. The birthweight was 3440 g. The mother had routine prenatal care for an uncomplicated pregnancy. The rashes were first observed at 4 weeks after delivery and were treated with co-trimoxazole cream; however, there was no response, which prompted a referral to the dermatology department. The infant was seen physically 3 weeks after the initial virtual review. There were erythematous annular rashes with slightly rolled edges on the scalp and soles of the feet. The remainder of the examination was normal. He was started on hydrocortisone–miconazole cream and reviewed again 6 weeks later, when the rash had faded considerably on the temporal sides of his scalp and resolved completely on his left foot. A differential diagnosis of fungal infection/granuloma annulare/resolving viral infection was considered. However, as the rash did not completely resolve after a further review 3 weeks later, the differential of neonatal LE was considered and screening for neonatal lupus was performed, which came back positive. Antinuclear antibody was positive (titre 360, speckled pattern), and anti-Ro/SSA antibodies were positive. He was prescribed clobetasone cream as treatment. Maternal serology was later checked, revealing anti-Ro/SSA, anti-La/SSB and high-titre antinuclear antibodies. However, the mother was completely asymptomatic. Preliminary cardiac and blood investigations by the paediatrician did not reveal any abnormality. Cutaneous involvement is usually self-limiting, though topical steroids may be needed in some cases. Cardiac involvement should be actively screened for, as pacemakers may be needed for atrioventricular block.

Neonatal Linear Immunoglobulin A Bullous Dermatosis: A Critical Case Recovering after Prompt Recognition, Intensive Management, and Breastfeeding Interruption - A Case Report

A 10-Year Retrospective Study of Neonatal Lupus Erythematous in China.

Linear IgA bullous dermatosis of childhood: Retrospective single‐center cohort

Linear IgA bullous dermatosis associated with immunotherapy

A case of bullous pemphigoid in infancy treated with local corticosteroids

Drug-induced linear immunoglobulin A bullous dermatosis: A French retrospective pharmacovigilance study of 69 cases

Prurigo nodularis-like linear IgA/IgG bullous dermatosis: a case report and literature review

Cutaneous legionellosis in an immunocompromised neonate

Linear IgA bullous dermatosis in a latin adolescent treated with cyclosporine and prednisone

Adult‐onset linear IgA bullous dermatosis: a retrospective single‐center cohort study? of 81 patients and literature review

Targeted serum proteome profiling reveals nicotinamide adenine dinucleotide phosphate (NADPH)-related biomarkers to discriminate linear IgA bullous disorder from dermatitis herpetiformis

Staphylococcal Infections and Neonatal Skin: Data from Literature and Suggestions for the Clinical Management from Four Challenging Patients

Neutrophils Are Critical In Linear Iga Bullous Dermatosis In Mice

Necrobiosis lipoidica in childhood: a review of literature with emphasis on therapy

Case report: Dupilumab: a promising treatment option for adult linear IgA bullous dermatosis with severe pruritus

Anti-NC16A IgA from linear IgA bullous dermatosis patients induce neutrophil-dependent subepidermal blistering in mice

A case of linear immunoglobulin A bullous dermatosis in a patient exposed to sun and an analgesic

P011 A case report of neonatal lupus erythematosus in a 3-month-old baby

Inpatient Management of Epidermolysis Bullosa: Consensus-Based Hands-On Instructions for Neonates and Post-Neonates

A review of neonatal lupus syndrome

Childhood Bullous Pemphigoid Treated by I.V. Immunoglobulin